<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ko">
	<id>http://www.urowiki.or.kr/wiki/index.php?action=history&amp;feed=atom&amp;title=%EC%B9%B8%EB%94%94%EB%8B%A4%EC%A7%88%EC%97%BC%EC%9D%98_%EC%B9%98%EB%A3%8C</id>
	<title>칸디다질염의 치료 - 편집 역사</title>
	<link rel="self" type="application/atom+xml" href="http://www.urowiki.or.kr/wiki/index.php?action=history&amp;feed=atom&amp;title=%EC%B9%B8%EB%94%94%EB%8B%A4%EC%A7%88%EC%97%BC%EC%9D%98_%EC%B9%98%EB%A3%8C"/>
	<link rel="alternate" type="text/html" href="http://www.urowiki.or.kr/wiki/index.php?title=%EC%B9%B8%EB%94%94%EB%8B%A4%EC%A7%88%EC%97%BC%EC%9D%98_%EC%B9%98%EB%A3%8C&amp;action=history"/>
	<updated>2026-05-05T23:12:14Z</updated>
	<subtitle>이 문서의 편집 역사</subtitle>
	<generator>MediaWiki 1.35.11</generator>
	<entry>
		<id>http://www.urowiki.or.kr/wiki/index.php?title=%EC%B9%B8%EB%94%94%EB%8B%A4%EC%A7%88%EC%97%BC%EC%9D%98_%EC%B9%98%EB%A3%8C&amp;diff=3567&amp;oldid=prev</id>
		<title>Sjlee: 새 문서: *남성파트너에대한치료는필요하지않으나남성파트너에게칸디다귀두포피염이있는경우 7일동안1일 2회국소적 azole계 약물을사용한다.&lt;ref na...</title>
		<link rel="alternate" type="text/html" href="http://www.urowiki.or.kr/wiki/index.php?title=%EC%B9%B8%EB%94%94%EB%8B%A4%EC%A7%88%EC%97%BC%EC%9D%98_%EC%B9%98%EB%A3%8C&amp;diff=3567&amp;oldid=prev"/>
		<updated>2019-07-01T01:57:39Z</updated>

		<summary type="html">&lt;p&gt;새 문서: *남성파트너에대한치료는필요하지않으나남성파트너에게칸디다귀두포피염이있는경우 7일동안1일 2회국소적 azole계 약물을사용한다.&amp;lt;ref na...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;새 문서&lt;/b&gt;&lt;/p&gt;&lt;div&gt;*남성파트너에대한치료는필요하지않으나남성파트너에게칸디다귀두포피염이있는경우 7일동안1일 2회국소적 azole계 약물을사용한다.&amp;lt;ref name=&amp;quot;Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush).&amp;quot;&amp;gt;Watson MC, Grimshaw JM, Bond CM, et al. Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush). Cochrane Database Syst Rev 2001;4:CD002845. &amp;lt;/ref&amp;gt;(근거수준 1)&lt;br /&gt;
&lt;br /&gt;
*증상이 없는 여성의 경우 치료가 요구되지는 않는다.&lt;br /&gt;
&lt;br /&gt;
*HIV 감염인은 일반환자와 동일하게치료한다.&lt;br /&gt;
&lt;br /&gt;
====권장요법====&lt;br /&gt;
&lt;br /&gt;
*단순 칸디다 질염의 국소 azole계과 경구 azole계의 효과는 동일하며, 치료효과는 90% 이상이다.&amp;lt;ref name=&amp;quot;Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush).&amp;quot;&amp;gt;Watson MC, Grimshaw JM, Bond CM, et al. Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush). Cochrane Database Syst Rev 2001;4:CD002845. &amp;lt;/ref&amp;gt;(근거수준 1)&lt;br /&gt;
&lt;br /&gt;
 A   권장요법&lt;br /&gt;
     ⋅질내에 azole계(clotrimazole, miconazole, ticonazole)의 질정삽입 혹은 크림도포&lt;br /&gt;
  또는 &lt;br /&gt;
     ⋅Fluconazole 150mg 경구 단회 요법 (임신 중에는 금기)&lt;br /&gt;
  Fluconazole 사용 전 임신 테스트를 시행하여 임신 중 사용을 금하며, 복용 중 피임의 필요성을 주지시킨다.&lt;br /&gt;
&lt;br /&gt;
====재발성 칸디다질염의 치료====&lt;br /&gt;
&lt;br /&gt;
*재발성이라 함은 1년에 4번 이상 감염되는 경우를 말한다.&lt;br /&gt;
&lt;br /&gt;
*재발성인경우 10-20%는 ''C. albicans''가 아닌 다른 원인균에 의한 칸디다 감염이다.&lt;br /&gt;
&lt;br /&gt;
*재발이 잦은 환자에서 예방적으로 국소적 또는경구적 azol계(fluconazole 150mg) 약물을 사용할 수 있다.&amp;lt;ref name=&amp;quot;Management of patients with recurrent vulvovaginal candidiasis.&amp;quot;&amp;gt;Sobel JD. Management of patients with recurrent vulvovaginal candidiasis. Drugs 2003;63:1059-1066. &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole.&amp;quot;&amp;gt;Sobel JD, Kapernick PS, Zervos M, et al. Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole. Am J Obstet Gynecol 2001;185:363-369. &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis.&amp;quot;&amp;gt;Sobel JD, Wiesenfeld HC, Martens M, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. N Engl J Med 2004;351:876-883. &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations.&amp;quot;&amp;gt;Sobel JD, Faro S, Force RW, et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol 1998;178:203-211. &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Single oral dose fluconazole compared with conventional clotrimazole topical therapy of Candida vaginitis.&amp;quot;&amp;gt;Sobel JD, Brooker D, Stein GE, et al. Single oral dose fluconazole compared with conventional clotrimazole topical therapy of Candida vaginitis. Fluconazole Vaginitis Study Group. Am J Obstet Gynecol 1995;172(4 Pt 1):1263-1268. &amp;lt;/ref&amp;gt;(근거수준 1)&lt;br /&gt;
&lt;br /&gt;
*초기 유도요법이 끝나면 바로 유지요법을 시작한다. 유지요법에는 azole계경구약물이나 질정이 사용된다.&amp;lt;ref name=&amp;quot;Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis.&amp;quot;&amp;gt;Sobel JD, Wiesenfeld HC, Martens M, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. N Engl J Med 2004;351:876-883. &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Practice guidelines for the treatment of candidiasis.&amp;quot;&amp;gt;Rex JH, Walsh TJ, Sobel JD, et al. Practice guidelines for the treatment of candidiasis. Clin Infect Dis 2000;30:662-678. &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Recurrent vulvovaginal candidiasis.&amp;quot;&amp;gt;Sobel JD. Recurrent vulvovaginal candidiasis. A prospective study of the efficacy of maintenance ketoconazole therapy. N Engl J Med 1986;315:1455-1458. &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Chronic or recurrent vaginal candidosis: short-term treatment and prophylaxis with itraconazole.&amp;quot;&amp;gt;Creatsas GC, Charalambidis VM, Zagotzidou EH, Anthopoulou HN, Michailidis DC, Aravantinos DI. Chronic or recurrent vaginal candidosis: short-term treatment and prophylaxis with itraconazole. Clin Ther 1993;15:662-671. &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Managing recurrent vulvovaginal candidiasis.&amp;quot;&amp;gt;Spinillo A, Colonna L, Piazzi G, Baltaro F, Monaco A, Ferrari A. Managing recurrent vulvovaginal candidiasis. Intermittent prevention with itraconazole. J Reprod Med 1997;42:83-87. &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Intermittent prophylactic treatment of recurrent vaginal candidiasis by postmenstrual application of a 500 mg clotrimazole vaginal tablet&amp;quot;&amp;gt;Roth AC, Milsom I, Forssman L, Wahlen P. Intermittent prophylactic treatment of recurrent vaginal candidiasis by postmenstrual application of a 500 mg clotrimazole vaginal tablet. Genitourin Med 1990;66:357-360. &amp;lt;/ref&amp;gt;(근거수준 1)&lt;br /&gt;
&lt;br /&gt;
 A   초기 유도요법&lt;br /&gt;
     ⋅Fluconazole 150mg 72시간 간격 3회 경구 요법&lt;br /&gt;
  또는&lt;br /&gt;
     ⋅질내에 azole 제제 10∼14일간 도포&lt;br /&gt;
     유지요법&lt;br /&gt;
     ⋅Fluconazole 150mg 1주일 1회 경구 요법 &lt;br /&gt;
  또는&lt;br /&gt;
     ⋅Ketoconazole 100mg 1일 1회 경구 요법&lt;br /&gt;
  또는&lt;br /&gt;
     ⋅Itraconazole 200∼400mg 1개월 1회 경구 요법&lt;br /&gt;
  또는&lt;br /&gt;
     ⋅Clotrimazole 500mg 질정 1개월 1회 질내 삽입&lt;br /&gt;
&lt;br /&gt;
*유지요법을 시행하지 않은 환자의 약 50%가 3개월 내에 재발한다.&lt;br /&gt;
&lt;br /&gt;
*유지요법은 초기 유도요법 직후 바로 시작한다.&lt;br /&gt;
&lt;br /&gt;
*유지요법은 최소 6개월 동안 사용한다.&lt;br /&gt;
&lt;br /&gt;
*재발율은 매우 높아 유지요법을 끊고 1-2개월 내에 약 60%정도이다.&amp;lt;ref name=&amp;quot;Management of patients with recurrent vulvovaginal candidiasis.&amp;quot;&amp;gt;Sobel JD. Management of patients with recurrent vulvovaginal candidiasis. Drugs 2003;63:1059-1066. &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations.&amp;quot;&amp;gt;Sobel JD, Faro S, Force RW, et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol 1998;178:203-211. &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*재발된 경우 다시 유지요법부터 시행한다.&lt;br /&gt;
&lt;br /&gt;
*오일 제제는 라텍스 콘돔과 여성용 피임기구 사용 시에 피임 실패가 일어날 수 있다.&lt;br /&gt;
&lt;br /&gt;
*임신 중 fluconizole은 금기이다.&lt;br /&gt;
&lt;br /&gt;
====''C. albicans''가 아닌 칸디다질염의 치료====&lt;br /&gt;
&lt;br /&gt;
*대부분은 ''C. glabrata''가 원인이며, ''C. albicans''에 비하여 azole치료에 10-100배 정도 감수성이 낮다.&lt;br /&gt;
&lt;br /&gt;
*최적의 권장치료는 아직 정립되지 않았다.&lt;br /&gt;
&lt;br /&gt;
*Fluconazle을 제외한 azole계 약물을 국소적 또는 경구적으로 오랜 기간 (7-14일) 치료하는 것이 권장된다.&amp;lt;ref name=&amp;quot;Management of patients with recurrent vulvovaginal candidiasis.&amp;quot;&amp;gt;Sobel JD. Management of patients with recurrent vulvovaginal candidiasis. Drugs 2003;63:1059-1066. &amp;lt;/ref&amp;gt;(근거수준 3)&lt;/div&gt;</summary>
		<author><name>Sjlee</name></author>
	</entry>
</feed>